(Q50929595)

25 March 2018

title

Curcumin serves as a human kv1.3 blocker to inhibit effector memory T lymphocyte activities. (English)

1 reference

25 March 2018

0 references

Yi-Tian Lian

1

1 reference

25 March 2018

Xiao-Fang Yang

2

1 reference

25 March 2018

Zhao-Hui Wang

3

1 reference

25 March 2018

Yong Yang

4

1 reference

25 March 2018

Ying Yang

5

1 reference

25 March 2018

Yan-Wen Shu

6

1 reference

25 March 2018

Long-Xian Cheng

7

1 reference

25 March 2018

Kun Liu

8

1 reference

25 March 2018

publication date

7 November 2012

1 reference

25 March 2018

published in

Phytotherapy Research

1 reference

25 March 2018

volume

27

1 reference

25 March 2018

issue

9

1 reference

25 March 2018

page(s)

1321-1327

1 reference

25 March 2018

Curcumin: the Indian solid gold

cites work

1 reference

Bioavailability of curcumin: problems and promises

21 January 2018

1 reference

Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases

21 January 2018

1 reference

Curcumin cross-links cystic fibrosis transmembrane conductance regulator (CFTR) polypeptides and potentiates CFTR channel activity by distinct mechanisms

21 January 2018

1 reference

Curcumin (Diferuloylmethane) Inhibits Constitutive and IL-6-Inducible STAT3 Phosphorylation in Human Multiple Myeloma Cells

21 January 2018

1 reference

Curcumin and autoimmune disease

21 January 2018

1 reference

Molecular properties and physiological roles of ion channels in the immune system

21 January 2018

1 reference

Voltage-gated potassium channels are required for human T lymphocyte activation

21 January 2018

1 reference

K+ channels as targets for specific immunomodulation

21 January 2018

1 reference

Curcumin inhibits bTREK-1 K+ channels and stimulates cortisol secretion from adrenocortical cells

21 January 2018

1 reference

Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies.

21 January 2018

1 reference

Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis

21 January 2018

1 reference

Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs

21 January 2018

1 reference

REVIEW: Curcumin and Alzheimer's Disease

21 January 2018

1 reference

Curcumin: from ancient medicine to current clinical trials.

21 January 2018

1 reference

Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes.

21 January 2018

1 reference

Neuroprotective and antiinflammatory properties of a novel demethylated curcuminoid.

21 January 2018

1 reference

Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets

21 January 2018

1 reference

Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes

21 January 2018

1 reference

Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes

21 January 2018

1 reference

Curcumin potently blocks Kv1.4 potassium channels

21 January 2018

1 reference

Molecular mechanisms for Kv1.3 potassium channel current inhibition by CD3/CD28 stimulation in Jurkat T cells

21 January 2018

1 reference

Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes

21 January 2018

1 reference

Kv1.3 potassium channels as a therapeutic target in multiple sclerosis

21 January 2018

1 reference

Curcumin protects human chondrocytes from IL-l1beta-induced inhibition of collagen type II and beta1-integrin expression and activation of caspase-3: an immunomorphological study

21 January 2018

1 reference

Pharmacokinetics and pharmacodynamics of curcumin

21 January 2018

1 reference

Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers

21 January 2018

1 reference

Immunomodulatory and therapeutic activity of curcumin

21 January 2018

1 reference

Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects

21 January 2018

1 reference

Ion channels in T lymphocytes: an update on facts, mechanisms and therapeutic targeting in autoimmune diseases

21 January 2018

1 reference

The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS

21 January 2018

1 reference

K+ channel expression during B cell differentiation: implications for immunomodulation and autoimmunity

21 January 2018

1 reference

Inhibition of Ca2+-Release–Activated Ca2+ Channel (CRAC) and K+ Channels by Curcumin in Jurkat-T Cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PTR.4863

1 reference

25 March 2018

PubMed ID

23132777

1 reference

25 March 2018